SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-061618
Filing Date
2022-03-01
Accepted
2022-03-01 17:09:54
Documents
8
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 d584309ds8.htm S-8 75648
2 EX-5.1 d584309dex51.htm EX-5.1 10135
3 EX-23.1 d584309dex231.htm EX-23.1 1747
4 EX-99.2 d584309dex992.htm EX-99.2 56153
5 EX-99.3 d584309dex993.htm EX-99.3 71155
6 EX-FILING FEES d584309dexfilingfees.htm EX-FILING FEES 16526
7 GRAPHIC g584309dsp10.jpg GRAPHIC 1645
8 GRAPHIC g584309dsp9.jpg GRAPHIC 2742
  Complete submission text file 0001193125-22-061618.txt   238848
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263170 | Film No.: 22699553
SIC: 2834 Pharmaceutical Preparations